Top line accelerating.
+23.7% YoY versus −14.5% prior. 3y CAGR +2.3%.
+23.7%We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Technology · Market Cap: $486.5B
Fundamentals as of 2026-03-29
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
The Question
How does LRCX compare?
Yes — Lam Research Corporation's 63.4% ROE ranks above the S&P 500 median, and D/E 0.96 stays within healthy bounds.
Financial story
Yes — Lam Research Corporation's 63.4% ROE shows strong capital efficiency, and its 0.96 debt-to-equity stays within healthy bounds.
Bottom line: LRCX currently has no legendary investor models qualifying — see /stock/LRCX/valuation for the per-model breakdown, but earns a C sector grade (53/100) in Technology. Use the per-tab analysis to form your own view. Drill into the valuation breakdown and sector ranking for the full picture.
Strength. Record everything. The March quarter brought $5.84B of revenue (+24% YoY) at a 35% operating margin, as AI multiplies the etch-and-deposition steps that Lam supplies — a wafer-fab-equipment market it now sizes near $140B for 2026. What a ~69x multiple makes of that record is the question this note takes apart.
Risk. At about 69x trailing earnings — the top of a ten-year range whose median sits near 20x — the price (~$367) already trades above the average analyst target (~$334), so the AI super-cycle looks more than priced in. The cost the multiple skips: wafer-fab equipment is the most cyclical capital good there is, and about a third of sales runs through a China tightening under US export rules.
Lam trades near 69 times trailing earnings — roughly three times its ten-year median of about 20 and at the very top of its decade range — because the market is pricing an AI-driven memory super-cycle as permanent. The March 2026 quarter was a record: $5.84 billion in revenue (+24% year over year), a 35.0% operating margin and $1.45 of EPS. The multiple assumes that level of demand and profitability holds rather than mean-reverting, which is a strong claim for a business whose spending has always moved in cycles.
Near $367 the stock already trades above its average analyst price target of about $334, so even the desks that spent June raising estimates see, on average, less upside than the price implies. Conservative intrinsic-value models — crediting a forward EPS growth of 20–25%, well above Lam's ~8% ten-year pace — land between roughly $86 and $218 a share. That doesn't make the price wrong, but it shows how much future the multiple has already borrowed: good news is now the expectation, not the surprise.
At 69 times earnings the price discounts four things going right at once: the AI memory and HBM build-out keeps wafer-fab spending climbing, Lam's record ~35% operating and ~31% net margins hold, its etch-and-deposition franchise keeps gaining content as chips go 3D, and China — about a third of revenue — stays resilient under tightening US rules. In short, it discounts peak demand and peak margins and a benign regulatory backdrop simultaneously, leaving little margin for a single disappointment.
China is Lam's largest market at about 34% of revenue — roughly $2 billion last quarter and about $6.2 billion in fiscal 2025 — down from a ~42% peak in 2024 and guided lower toward ~30%. The risk is regulatory: late-2025 US rules revoked the Validated End-User status for foreign-owned fabs in China effective December 31, 2025, and will license existing fabs but not expansions. Applied Materials, similarly exposed, quantified the hit at roughly $600 million of 2026 revenue, a useful read-across for Lam.
Wafer-fab equipment is one of the most cyclical markets in technology, and Lam is the most memory-levered of the big three, more tied to NAND and DRAM capital spending than Applied Materials or KLA. Memory budgets swing hard: today's record ~35% operating margin reflects a cycle peak, not a steady state. As recently as the 2022–2023 downturn, semicap revenue and margins compressed and Lam's multiple fell toward the single digits — the ~8x low still in its ten-year range — which is why buying record earnings at 69x carries real cycle risk.
The consensus 12-month target is about $334 across roughly 34 analysts, with a range from $220 to a Street-high $450 (Citigroup). Notably, that average sits below the ~$367 price even after a June wave of upgrades — Cantor and Raymond James to $425, Oppenheimer to $400, UBS to $375 — so the most bullish desks still see room while the average reads the stock as already past fair value. MainRatios' own conservative models land far lower, around $86–$218, because they discount Lam's historical growth rather than the AI-cycle premium.
See exactly where LRCX ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingLRCX sits at #67 in Technology with a C grade (53/100).

| Firm | Target | Upside | vs. price | Rating | Recent move | Date |
|---|---|---|---|---|---|---|
![]() Citigroup Atif Malik | $450 | +16% | Buy | raised 315 to 450 (Street-high) | Jun 17 | |
CF Cantor Fitzgerald C.J. Muse | $425 |

| +9% |
| Overweight |
| raised 320 to 425 |
| Jun 10 |
RJ Raymond James | $425 | +9% | Outperform | set target | Jun 10 |
RR Rothschild & Co Redburn | $420 | +8% | Buy | raised 305 to 420 | Jun 17 |
OP Oppenheimer Edward Yang | $400 | +3% | Outperform | raised 330 to 400 | Jun 15 |
UG UBS Group Timothy Arcuri | $375 | −4% | Buy | raised 310 to 375 | Jun 9 |
![]() Barclays Tom O'Malley | $335 | −14% | Overweight | raised 275 to 335 | Jun 11 |
+23.7% YoY versus −14.5% prior. 3y CAGR +2.3%.
+23.7%Net margin 29.1% versus 25.7% prior (+3.4pp). Operating 32.0%.
29.1%P/E 57.2x — 134% above the 5y median of 24.5x. Forward 68.4x signals EPS contraction next year.
57.2xStructural-shift event, not a quarterly print. The marginal-dollar analysis: $650B incremental 2026 hyperscaler capex MUST land somewhere in the semiconductor supply chain — semis don't produce demand exogenously, they are derivative-demand from compute spend. WSTS projects industry revenue at ~$975B (+26% YoY), Bank of America's Vivek Arya models closer to 30%, which would cross the $1T threshold for the first time in history. Both estimates are anchored on SEC-filed capex commitments, not analyst speculation.
The smoking gun is the pace of upward revision — among the fastest in semiconductor-cycle history. Consensus 2026 hyperscaler capex moved from ~$465B at the start of Q3 2025 earnings season to ~$527B by the end of the calls, then pushed toward $650B within weeks. Microsoft, Alphabet, Amazon, and Meta account for roughly 80% of incremental dollar flow. What makes 2026 different is composition: the marginal dollar is shifting from pure merchant GPUs toward custom silicon (Google TPU, Meta MTIA), high-bandwidth memory (HBM3E sold out through 2026), and advanced packaging capacity. This composition shift rewires who captures the margin.
Forward implication: the picks-and-shovels trade has rotated one tier downstream from accelerators to memory and wafer-fab equipment. Memory is the sleeper trade — HBM3E pricing power has returned to the memory oligopoly for the first time since 2018 cycle peak, with MU contract pricing locked in well in advance. The equipment trio (AMAT, LRCX, KLAC) sits at ~28x forward earnings with backlogs extending into 2027 and less single-customer concentration than accelerator vendors. Power is now the binding constraint, not chip supply — interconnection queue times in several US grid regions exceed four years, and transformer lead times have blown out from months to years. This makes LIN (industrial gas), nuclear utilities, and grid infrastructure unconventional AI trades.
Counter-narrative: the Chanos circular-revenue critique — OpenAI raises money, spends it on MSFT Azure compute, MSFT justifies larger NVDA orders, NVDA invests back into OpenAI — resembles late-1990s telecom vendor financing. The counter: today's hyperscalers collectively produce hundreds of billions in operating cash flow annually; they can fund capex out of internally generated cash without stretching the balance sheet. The real Q2-Q3 risk is forward, not backward: the first hyperscaler to cut 2027 capex growth guidance by even 10% on a call would reprice the entire semiconductor complex overnight. That's the scenario every long-only semi fund manager is quietly stress-testing — but it hasn't happened, and the Q1 + confirmed 2026 capex commitments captured by this news event remain unambiguously bullish.